Navigation Links
New Drug Shows Promise in Use With Coronary Stents
Date:3/29/2008

Antiplatelet prasugrel may protect better than Plavix, study shows

SATURDAY, March 29 (HealthDay News) -- Treatment with a new antiplatelet drug called prasugrel may be better than standard treatment in protecting against blocked blood flow in patients with at least one coronary stent, according to a new international study.

Coronary stents are used to treat narrowing of arteries that supply blood to the heart. But stents can result in blood clots that can block the stented artery, a condition called stent thrombosis. To prevent this, patients take antiplatelet medications or anticoagulants after they've had stents inserted in arteries. The standard treatment uses the drug clopidogrel (Plavix) with aspirin.

Both prasugrel (Effient) and clopidogrel belong to a group of compounds called thienopyridines.

In this study, Dr. Stephen Wiviott, of Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues analyzed data on 12,844 patients with different types of heart stents who were treated with either prasugrel plus aspirin or clopidogrel plus aspirin.

They found that patients who received intensive antiplatelet therapy with prasugrel had fewer "ischemic events," including stent thrombosis, than patients who received clopidogrel. The type of stent was not a factor.

"These data highlight the importance of aggressive antiplatelet therapy to reduce ischemic events in patients with acute coronary syndromes undergoing percutaneous coronary intervention," the study authors concluded. "When balancing risks and benefits of strategies to prevent ischemic events, consideration should be given to patient characteristics, including risk of bleeding and ischemic events as well as stent and procedural characteristics."

The study was to be presented Saturday at the American College of Cardiology annual meeting, in Chicago, and appears online in The Lancet. It will be published in an upcoming print issue of the journal.

More information

The U.S. National Library of Medicine has more about stents.



-- Robert Preidt



SOURCE: The Lancet, news release, March 29, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. New research shows how chronic stress worsens neurodegenerative disease course
3. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
4. Circulating fats kill transplanted pancreas cells, study shows
5. New Heart Pump Shows Promise in Trial
6. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
7. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
10. Avocados may help prevent oral cancer, OSU study shows
11. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug Shows Promise in Use With Coronary Stents
(Date:3/24/2017)... ... March 24, 2017 , ... ... Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate about ... what is often a very difficult and challenging time.” , A Certified Medical ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation ... and college Bible teacher residing in North Carolina with his wife, Anna Marie. He ... them with six grandchildren. David is also the author of “Shadow and Substance.” , ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World Health Organization ... could be four million Zika-related cases in the Americas within the next year. Lyme ... cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating ... communities, 16 more public health departments have been awarded national accreditation through the ... million people into the expanding network of communities across the nation whose health ...
(Date:3/23/2017)... ... ... The IoT (Internet of Things) is revolutionizing the way the world operates. ... individual consumers alike. Laboratories can maximize their profit margin by increasing throughput. ... to $11 trillion dollars by the year 2025. McKinsey expects the IoT to have ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, 2017-2035 ... market of deep learning solutions within the healthcare domain. Primarily driven ... a novel solution to generate relevant insights from medical data. ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... to their offering. ... report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and Rest ... through 2022. Also, a six-year historic analysis is provided for these markets. ...
(Date:3/24/2017)... March 23, 2017  Mirabilis Medical, a ... technology for non-invasive surgery, announced today CE Mark ... treatment of uterine fibroids throughout the European Union.  ... approval from the US Food and Drug Administration ... System in the United States.  The Mirabilis System ...
Breaking Medicine Technology: